Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006435 · ClinicalTrials.gov registry record
Study of Plexiform Neurofibromas in Neurofibromatosis Type 1
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 24
- Enrollment target
NCT00006435: Completed study, sponsored by National Cancer Institute (NCI).
NCT00006435 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00006435 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
Background: -Plexiform neurofibromas in patients with NF1 are a significant cause of morbidity but little is known about the natural history of these lesions. Objectives: * The purpose of this study is to monitor the natural history of plexiform neurofibromas and to evaluate the usefulness of volumetric MRI tumor measurements in this disease. * Other goals of the study are to provide a body of normative data on the growth rate of plexiform neurofibromas and to establish a tissue repository and pathology review center to allow future studies of the pathogenesis of neurofibromas and clinical trials of potential therapeutic agents. Design \- This study is coordinated by Dr. Bruce Korf, and was initiated when he was at the Partners Center for Human Genetics, Boston, MA.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2001-05-18 |
| Est. Completion | 2020-05-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00006435
The ClinicalTrials.gov registry entry for NCT00006435 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00006435 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00006435 about?
NCT00006435 is a clinical study titled "Study of Plexiform Neurofibromas in Neurofibromatosis Type 1". Background: -Plexiform neurofibromas in patients with NF1 are a significant cause of morbidity but little is known about the natural history of these lesions. Objectives: * The purpose of this study is to monitor the natural history of plexiform neurofibromas and to evaluate the usefulness of vol...
What is the current status of trial NCT00006435?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2001-05-18. Estimated completion is 2020-05-01.
Who is sponsoring clinical trial NCT00006435?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.